Back to search
Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency trials you may qualify forThe purpose of this study is to evaluate the Safety and Efficacy of Gene Therapy of the severe combined immunodeficiency (SCID) caused by mutations in the human…
This study aims to determine if a new method can be used to treat Artemis-deficient Severe Combined Immunodeficiency (ART-SCID), a severe form of primary immuno…